Purchase this article with an account.
N.G. Ziakas, N.S. Georgiadis, K.G. Boboridis, D.G. Mikropoulos; Autologous Serum Application for the Management of Recurrent Corneal Erosions . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1380.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To evaluate the use of autologous serum for the treatment of recurrent corneal erosions Methods: Retrospective study of 21 consecutive patients to whom autologous serum was prescribed for recurrent corneal erosions. Various other treatment modalities including artificial tears, ointments, bandage contact lenses and anterior stoma punctures, had already been used in all patients who already have been symptomatic for over 18 months. Autologous serum was prescribed for 6 months in a 6 times daily dosage for the first 3 months reduced to 4 times daily for the remaining 3 month period Results: The follow-up period ranged from 12 to 48 months. None of the patients had recurrence while under treatment. In 2 patients a recurrence occurred in the follow up period while the other 19 remained symptom free throughout the follow up period Conclusions: Autologous serum was proven to be an effective treatment modality for the treatment of recurrent corneal erosions
This PDF is available to Subscribers Only